AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $373,000 | -58.3% | 27,500 | -74.8% | 0.00% | -50.0% |
Q1 2019 | $894,000 | +78.8% | 109,199 | +108.0% | 0.00% | +100.0% |
Q1 2018 | $500,000 | -79.0% | 52,500 | -56.6% | 0.00% | -83.3% |
Q3 2017 | $2,382,000 | +326.1% | 121,089 | +211.3% | 0.01% | +200.0% |
Q2 2017 | $559,000 | +314.1% | 38,900 | +165.0% | 0.00% | – |
Q1 2017 | $135,000 | – | 14,678 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |